Archives of Neurology · 1961 · 122 citations · 18 references
MedicinePharmacologyPharmacotherapyClinical PharmacologyNeuropharmacologyPharmacodynamicsCerebral Blood FlowCerebrovascular PhysiologyHemodynamic PharmacologyCerebral Blood Flow AlterationsCerebral Blood Flow EffectsCerebral Blood Flow QuantificationHemodynamic Drug EffectsHepatic Encephalopathy ManagementIncreased Intracranial PressureVascular Insufficiency
Carbonic anhydrase inhibitors have been used in clinical medicine as diuretics,<sup>1-3</sup>as anticonvulsants,<sup>4,5</sup>to reduce intraocular tension,<sup>6,7</sup>to lower intracranial pressure,<sup>8,9</sup>and in the treatment of respiratory insufficiency.<sup>10,11</sup>In the course of investigation of the effects of acetazolamide in hepatic encephalopathy, Posner and Plum<sup>12</sup>observed without comment a considerable increase in rate of cerebral blood flow after intravenous administration of 1 to 2 gm. of acetazolamide. Such a cerebral circulatory change had previously been considered to account for the brief elevation of cerebrospinal fluid pressure after intravenous acetazolamide.<sup>9,13</sup> In view of these findings, we felt that the usefulness of carbonic anhydrase inhibitors might be extended to the management of patients with intermittent cerebral vascular insufficiency. In this preliminary report, observations of the quantitative cerebral hemodynamic effects of intravenous acetazolamide are presented. In several subjects, the effects of inhalation of 5% CO<sub>2</sub>were
18
Quantitative Clinical Chemistry
John P. Peters, Donald D. Van Slyke · American Journal of Clinical Pathology · 1932 · 1.5K citations · Full text
Peritz Scheinberg, Eugene A. Stead · Journal of Clinical Investigation · 1949 · 371 citations · Full text
Medicine, Neuroscience, Physiology +13